SABCS 2016: The Search for an Effective and Safe PI3K-Inhibitor
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Recent studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce who benefits from...
The 2024 AACR June L. Biedler Prize for Cancer Journalism winners were honored during the AACR Annual Meeting 2024.
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
What experts forecast for cancer research and treatment in 2024. Part 1: Catherine J. Wu, MD, FAACR, on...
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
In part 2 of our 2024 Experts Forecast, Robert A. Winn, MD, FAACR, discusses ways to achieve health equity.
The year 2022 will be remembered as the time when the emergency phase of the COVID-19 pandemic began to...
Researchers around the world are designing and implementing methods to increase access to cancer care in low-resource areas.
The second day of the AACR Virtual Annual Meeting II began with a clinical trials plenary session. Two of the session’s presentations, which focused on immunotherapy clinical...
Experts discussed "Discovery Science in Early Cancer Biology and Interception" at a plenary during the AACR Annual Meeting 2024.
Patient advocates at the AACR Annual meeting 2024 brought their perspectives to cancer researchers.
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
Charles Swanton, MD, PhD, FAACR, spoke on the role chromosomal instability plays in breast cancer evolution.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
International award and grant recipients from the Annual Meeting 2024 talk about defeating cancer globally.
Lobular breast cancer accounts for 15% of all breast cancer cases, but it is understudied.
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
The women bustle around a warm, colorful kitchen, making tamales for an upcoming family party. A woman in her...
A childhood cancer survivor becomes a childhood cancer researcher.
In the second post of the "Meet the Chairs" series, Mark Stewart, PhD, chair of the AACR's Associate Member...
Editor’s Note: Raquel Castellanos is assistant director of Scientific Programs at the American Association for Cancer Research. She and...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
The AACR Annual Meeting 2024 Opening Ceremony showcased impactful initiatives impacting cancer research.
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.